Eric Quéméneur
Chief Tech/Sci/R&D Officer at TRANSGENE
Eric Quéméneur active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TRANSGENE | Chief Tech/Sci/R&D Officer | 2014-08-31 | - |
| ELSALYS BIOTECH | Director/Board Member | - | - |
| Chief Tech/Sci/R&D Officer | - | - |
Career history of Eric Quéméneur
Former positions of Eric Quéméneur
| Companies | Position | Start | End |
|---|---|---|---|
| Comité de l’énergie Atomique | Corporate Officer/Principal | 2010-08-31 | 2014-08-31 |
Training of Eric Quéméneur
| Université Claude Bernard Lyon 1 | Doctorate Degree |
| Institut National des Sciences Appliquées de Lyon | Undergraduate Degree |
Statistics
International
| France | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Government | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Private companies | 2 |
|---|---|
| Comité de l’énergie Atomique | Government |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
- Stock Market
- Insiders
- Eric Quéméneur
- Experience
